STAAR SURGICAL CO (STAA) Stock Price, Quote, News and Overview
NASDAQ:STAA - Nasdaq - US8523123052 - Common Stock - Currency: USD
STAA Quote, Performance and Key Statistics
16.87
+0.02 (+0.12%)
The current stock price of STAA is 16.87 USD. In the past month the price decreased by -29.56%. In the past year, price decreased by -45%.
STAA Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ALC | ALCON INC | 29.9 | 45.13B | ||
| COO | COOPER COS INC/THE | 23.91 | 17.66B | ||
| ALGN | ALIGN TECHNOLOGY INC | 20.39 | 14.22B | ||
| SOLV | SOLVENTUM CORP | 17.55 | 12.61B | ||
| MMSI | MERIT MEDICAL SYSTEMS INC | 30.7 | 6.01B | ||
| BLCO | BAUSCH + LOMB CORP | 25.4 | 5.55B | ||
| LNTH | LANTHEUS HOLDINGS INC | 11.27 | 5.44B | ||
| ICUI | ICU MEDICAL INC | 27.69 | 3.85B | ||
| XRAY | DENTSPLY SIRONA INC | 10.14 | 3.73B | ||
| HAE | HAEMONETICS CORP/MASS | 14.9 | 3.17B | ||
| NEOG | NEOGEN CORP | 25.1 | 2.18B | ||
| UFPT | UFP TECHNOLOGIES INC | 36.31 | 1.95B |
Related stock screener links
About STAA
Company Profile
STAAR Surgical Co. engages in the design, development, manufacture, and sale of ophthalmic surgical products. The company is headquartered in Monrovia California, California and currently employs 1,056 full-time employees. These lenses provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. The firm is a manufacturer of lenses used worldwide in corrective or refractive surgery. The company sells its products in approximately 75 countries, with direct distribution in Japan, Germany, Spain, the United States, Canada, the United Kingdom, and Singapore, with a combination of direct distribution and independent distribution in China, Korea, India, France, Benelux, and Italy. The firm markets and sells ICLs for refractive surgery to treat myopia (nearsightedness) as its EVO family of lenses. The Company’s EVO family of lenses includes its EVO ICL, EVO+ ICL, and EVO Visian ICL. The firm also markets and sells an ICL lens to treat hyperopia (farsightedness), which is called Visian ICL.
Company Info
STAAR SURGICAL CO
1911 Walker Ave
Monrovia California CALIFORNIA 92630 US
CEO: Caren Mason
Employees: 1057
Company Website: https://www.staar.com/
Investor Relations: https://investors.staar.com
Phone: 16263037902
STAAR SURGICAL CO / STAA FAQ
What is the stock price of STAAR SURGICAL CO today?
The current stock price of STAA is 16.87 USD. The price increased by 0.12% in the last trading session.
What is the ticker symbol for STAAR SURGICAL CO stock?
The exchange symbol of STAAR SURGICAL CO is STAA and it is listed on the Nasdaq exchange.
On which exchange is STAA stock listed?
STAA stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for STAAR SURGICAL CO stock?
20 analysts have analysed STAA and the average price target is 22.51 USD. This implies a price increase of 33.4% is expected in the next year compared to the current price of 16.87. Check the STAAR SURGICAL CO stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is STAAR SURGICAL CO worth?
STAAR SURGICAL CO (STAA) has a market capitalization of 831.35M USD. This makes STAA a Small Cap stock.
How many employees does STAAR SURGICAL CO have?
STAAR SURGICAL CO (STAA) currently has 1057 employees.
What are the support and resistance levels for STAAR SURGICAL CO (STAA) stock?
STAAR SURGICAL CO (STAA) has a resistance level at 17.77. Check the full technical report for a detailed analysis of STAA support and resistance levels.
Is STAAR SURGICAL CO (STAA) expected to grow?
The Revenue of STAAR SURGICAL CO (STAA) is expected to decline by -23.81% in the next year. Check the estimates tab for more information on the STAA EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy STAAR SURGICAL CO (STAA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of STAA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of STAA, evaluating the profitability, health, valuation and growth aspects
- STAAR SURGICAL CO (STAA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- STAAR SURGICAL CO (STAA) Sales and EPS estimates to see what analysts future expectations are.
- STAAR SURGICAL CO (STAA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- STAAR SURGICAL CO (STAA) Insider and Institutional Ownership to learn about the owners and their transactions.
- STAAR SURGICAL CO (STAA) Stock Chart to make your own analysis
- STAAR SURGICAL CO (STAA) Latest news and press-releases to stay up to date.
Does STAAR SURGICAL CO (STAA) stock pay dividends?
STAA does not pay a dividend.
When does STAAR SURGICAL CO (STAA) report earnings?
STAAR SURGICAL CO (STAA) will report earnings on 2025-05-05, after the market close.
What is the Price/Earnings (PE) ratio of STAAR SURGICAL CO (STAA)?
The PE ratio for STAAR SURGICAL CO (STAA) is 51.12. This is based on the reported non-GAAP earnings per share of 0.33 and the current share price of 16.87 USD. Check the full fundamental report for a full analysis of the valuation metrics for STAA.
What is the Short Interest ratio of STAAR SURGICAL CO (STAA) stock?
The outstanding short interest for STAAR SURGICAL CO (STAA) is 8.04% of its float. Check the ownership tab for more information on the STAA short interest.
STAA Technical Analysis
STAA Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to STAA. While STAA has a great health rating, its profitability is only average at the moment.
STAA Financial Highlights
Over the last trailing twelve months STAA reported a non-GAAP Earnings per Share(EPS) of 0.33. The EPS decreased by -45% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -3.97% | ||
| ROE | -5.09% | ||
| Debt/Equity | 0 |
STAA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 79% to STAA. The Buy consensus is the average rating of analysts ratings from 20 analysts.
For the next year, analysts expect an EPS growth of -373.06% and a revenue growth -23.81% for STAA